7 research outputs found
Rapid 3D Reconstruction Guided Embolization for Catastrophic Bleeding Following Vacuum Assisted Breast Biopsy; A Case Report and Review of the Literature
The most clinically significant complication associated with stereotactic core needle biopsy of the breast is hematoma formation, which only occurs in less than 1% of biopsies and may require treatment. Cases of uncontrollable bleeding, refractory to repeated compression, resulting from biopsy are exceedingly rare. We present a case of catastrophic, uncontrollable bleeding and large hematoma formation resulting from stereotactic vacuum-assisted breast biopsy of a breast mass identified in screening mammography. Percutaneous embolization was planned and guided using 3D reconstructions from computed tomographic angiography, and bleeding was successfully controlled with micro-coil embolization
Abducens Nerve Palsy as Initial Presentation of Multiple Myeloma and Intracranial Plasmacytoma
Central Nervous System (CNS) involvement in multiple myeloma and/or multifocal solitary plasmacytoma is rare. Although they are unique entities, multiple myeloma (MM) and plasmacytoma represent a spectrum of plasma cell neoplastic diseases that can sometimes occur concurrently. Plasmacytomas very often present as late-stage sequelae of MM. In this case report, we report a 53-year-old female presenting with right abducens cranial nerve (CN) VI palsy as an initial presentation secondary to lesion of the right clivus
Poly-ADP-Ribose-Polymerase as a Therapeutic Target in Paediatric Diffuse Intrinsic Pontine Glioma and Paediatric High Grade Astrocytoma
Paediatric high-grade astrocytomas (pHGA) and diffuse-intrinsic-pontine-gliomas (DIPG) are devastating paediatric malignancies for which there are no effective therapies. Previous evidence found Poly-ADP-Ribose-Polymerase 1 (PARP1) over-expressed in DIPG and pHGA. Immunohistochemical and western-blot analysis was performed on pHGA and DIPG patient tumour samples and cell lines to establish PARP1 expression. Three PARP inhibitors, Veliparib, Olaparib, and Niraparib, were used to study PARP inhibition in multiple pHGA and DIPG cell lines and intracranial xenografts. PARP1 was expressed in the majority of pHGA and DIPG patient samples and cell lines and PARP inhibition in vitro resulted in growth arrest and/or apoptosis. Niraparib was the most effective monotherapeutic agent. Niraparib reduced the rate of DNA repair and sensitized cells in vitro to ionizing radiation (IR). In vivo, Niraparib when combined with IR, inhibited PARP1 and extended survival by 40%. Therefore, PARP1 may serve as a potential therapeutic target in pHGA and DIPG.M.Sc
Metabolic Alterations in Cancer Cells and the Emerging Role of Oncometabolites as Drivers of Neoplastic Change
The mitochondrion is an important organelle and provides energy for a plethora of intracellular reactions. Metabolic dysregulation has dire consequences for the cell, and alteration in metabolism has been identified in multiple disease states—cancer being one. Otto Warburg demonstrated that cancer cells, in the presence of oxygen, undergo glycolysis by reprogramming their metabolism—termed “aerobic glycolysis”. Alterations in metabolism enable cancer cells to gain a growth advantage by obtaining precursors for macromolecule biosynthesis, such as nucleic acids and lipids. To date, several molecules, termed “oncometabolites”, have been identified to be elevated in cancer cells and arise from mutations in nuclear encoded mitochondrial enzymes. Furthermore, there is evidence that oncometabolites can affect mitochondrial dynamics. It is believed that oncometabolites can assist in reprogramming enzymatic pathways and providing cancer cells with selective advantages. In this review, we will touch upon the effects of normal and aberrant mitochondrial metabolism in normal and cancer cells, the advantages of metabolic reprogramming, effects of oncometabolites on metabolism and mitochondrial dynamics and therapies aimed at targeting oncometabolites and metabolic aberrations
Abducens Nerve Palsy as Initial Presentation of Multiple Myeloma and Intracranial Plasmacytoma
Central Nervous System (CNS) involvement in multiple myeloma and/or multifocal solitary plasmacytoma is rare. Although they are unique entities, multiple myeloma (MM) and plasmacytoma represent a spectrum of plasma cell neoplastic diseases that can sometimes occur concurrently. Plasmacytomas very often present as late-stage sequelae of MM. In this case report, we report a 53-year-old female presenting with right abducens cranial nerve (CN) VI palsy as an initial presentation secondary to lesion of the right clivus.Medicine, Faculty ofNon UBCReviewedFacult